Kristen Doyle was approved by the governing body of the Cancer Prevention and Research Institute of Texas as the agency’s new CEO beginning July 1. Doyle, currently deputy executive officer and general counsel, will succeed Wayne Roberts who will step down on June 30 after 12 years as chief executive.
The governing body of the Cancer Prevention and Research Institute of Texas approved $51.8 million in grants to advance the state’s fight against cancer. The grants are a mix of academic research recruitment grants and product development research projects.
The Lymphoma Research Foundation has awarded 28 new research grants in 2024, amounting to $3.5 million to cancer researchers who will advance understanding of lymphoma and lay the foundation for improved patient care.
The International Agency for Research on Cancer welcomed the Kingdom of Saudi Arabia as a new participating state, underscoring the commitment to advancing cancer research and prevention in the country.
Daniel M. Geynisman was named the editor-in-chief of JNCCN—Journal of the National Comprehensive Cancer Network.Â
David Tom Cooke was named associate director of the Office of Inclusion, Diversity, Equity and Accessibility (IDEAL) at University of California Davis Comprehensive Cancer Center.
Ronny Bell was named associate director of cancer care access and excellence at UNC Lineberger Comprehensive Cancer Center.Â
Dustin A. Deming, Heather A. Wakelee, and Tarek H. Mouhieddine were named recipients of the ECOG-ACRIN Cancer Research Group annual scientific awards, which are funded by the ECOG Research & Education Foundation.
The Association of Cancer Care Centers named the winning cancer care programs for its 14th annual ACCC Innovator Awards, which recognize innovative and replicable solutions for oncology care from cancer centers nationwide.
Norman Wolmark, chairman of the NSABP Foundation Inc., and group chair and contact principal investigator of NRG Oncology, received the 2024 American Surgical Association Medallion for Advancement of Surgical Care at the American Surgical Association’s 144th annual meeting in Washington, DC.
